BETHANY WAIT: Open Payments
NPI 1447458096 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 19 payments from 11 companies in 2025. Trend: 2023 $374 · 2024 $500 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $88 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $45 |
| Dexcom, Inc. | 2 | $34 |
| Indivior Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, Dexcom G6 Transmitter, SUBLOCADE, MAVYRET, ARISTADA, PENMENVY, Qelbree.
Industry payments across IN — which companies pay providers there.
